Weekly Quick Hits (Philly) – Week of August 28, 2023

Published on :

Tris Pharma picks up a $16.6 million NIAID grant, Penn receives a $19 million grant from the NIH, and Bristol Myers Squibb awarded $1 million to Drexel’s Biomed Engineering Program. For these and other life science stories, continue reading.

Johns Hopkins Wilmer Eye Institute Receives $20 Million Donation from T. Boone Pickens Foundation

Published on :

Johns Hopkins Wilmer Eye Institute Receives $20 Million Donation from T. Boone Pickens Foundation Additional funding from the T. Boone Pickens Foundation will create additional Professorships for young researchers at [….]

Weekly Quick Hits (BHCR) – Week of August 14, 2023

Published on :

MyMD Pharmaceuticals advances its oral TNF-α inhibitor MYMD-1 into a Phase II study in patients with active rheumatoid arthritis. Non-profit pharma company Caring Cross, a Virginia Tech spinout, is featured in a paper on affordable and accessible gene therapies. Also in Virginia, CvilleBioHub secures an innovation grant from the Virginia Innovation Partnership Corporation.

Weekly Quick Hits (Research Triangle Park) – Week of August 7, 2023

Published on :

While the economy has slowed momentum for a number of RTP-based life sciences organizations, including a few bankruptcy filings earlier this summer, several companies are eying near-term growth, including Chiesi and Clinetic. Milestone Pharmaceuticals is also on the cusp of new growth, which could follow a planned Q3 NDA for its experimental PSVT treatment.